| Characteristic | HIV-, N = 551 | HIV+ART+, N = 1111 | p-value2 |
|---|---|---|---|
| cotrimoxazole | 0.3 | ||
| Susceptible | 7 (13%) | 8 (7.2%) | |
| non-susceptible | 48 (87%) | 103 (93%) | |
| tetracycline | 0.082 | ||
| Susceptible | 29 (53%) | 74 (67%) | |
| non-susceptible | 26 (47%) | 37 (33%) | |
| oxacillin | 0.011 | ||
| Susceptible | 22 (40%) | 58 (52%) | |
| Intermediate | 21 (38%) | 46 (41%) | |
| Resistant | 12 (22%) | 7 (6.3%) | |
| chloramphenicol | >0.9 | ||
| Susceptible | 52 (95%) | 106 (95%) | |
| non-susceptible | 3 (5.5%) | 5 (4.5%) | |
| erythromycin | 0.2 | ||
| Susceptible | 35 (64%) | 81 (73%) | |
| non-susceptible | 20 (36%) | 30 (27%) | |
| MDR | 0.4 | ||
| non | 38 (69%) | 84 (76%) | |
| MDR | 17 (31%) | 27 (24%) | |
|
1
n (%)
2
Fisher's exact test; Pearson's Chi-squared test
|
|||